Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effect of an Oral Beta-2 Agonist on Respiratory Muscle Strength in SCI

NCT02508311 is registered in ClinicalTrials.gov with VA Office of Research and Development as lead sponsor.

NCT NCT02508311
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02508311 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effect of an Oral Beta-2 Agonist on Respiratory Muscle Strength in SCI
Lead sponsor
VA Office of Research and Development
Phase
Phase 4
Overall status
Terminated
Start date
June 1, 2016
Completion date
February 28, 2023
Enrollment
1 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

respiratory muscle weakness, spinal cord injury